| DC Field | Value | Language |
|---|
| dc.contributor.author | Tanujaya, A. F. | - |
| dc.contributor.author | Anggraini, D. | - |
| dc.contributor.author | Nurhan, A. D. | - |
| dc.date.accessioned | 2025-01-24T08:17:10Z | - |
| dc.date.available | 2025-01-24T08:17:10Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | Tanujaya, A.F. CAR-T cells: prospective genetic engineering approach to orchestrate solid tumor in lung cancer / A.F. Tanujaya, D. Anggraini, A.D. Nurhan // Research Results in Pharmacology. - 2024. - Vol.10, №4.-P. 77-86. - Doi: 10.18413/rrpharmacology.10.522. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/64420 | - |
| dc.description.abstract | CAR-T acts to overcome lung cancer by targeting several receptors, such as mesothelin and c-Met. Several generations have also evolved to more specific and effective therapy | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | lung cancer | ru |
| dc.subject | solid tumor | ru |
| dc.subject | chimeric antigen receptor | ru |
| dc.subject | CAR-T modification | ru |
| dc.subject | genetic engineering | ru |
| dc.title | CAR-T cells: prospective genetic engineering approach to orchestrate solid tumor in lung cancer | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 10, № 4
|
